Live Breaking News & Updates on Generium Commercial License

Stay updated with breaking news from Generium commercial license. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Selexis SA: Launch of Generium's Omalizumab Biosimilar for Atopic Bronchial Asthma Marks Selexis' Ninth Commercial Product

Third Biosimilar to Reach the Market Under Selexis/Generium Commercial License Agreements Selexis SA and Generium JSC today announced that Genolar, Generium's biosimilar of omalizumab, is now commercially ....

Arkhangel Skaya Oblast , Kostenloser Wertpapierhandel , Selexis Generium , Robert Meister , Daniil Talyanskiy , Vsevolod Letsko , Roland Hecht , Mike Beyer , Selexis Company Inquiries , Sam Brown Inc , Corporate Communications , Life Sciences , Business Development , Third Biosimilar , Market Under , Generium Commercial License , Selexis Genetic Elements ,